Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-17-012337
Filing Date
2017-03-16
Accepted
2017-03-16 16:16:54
Documents
60
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-K 12-31-2016 form10k.htm 10-K 1453177
2 EXHIBIT 21.1 ex21_1.htm EX-21.1 1667
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2823
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 11906
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5132
12 image0.jpg GRAPHIC 50608
  Complete submission text file 0001140361-17-012337.txt   5791298

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bstc-20161231.xml EX-101.INS 1029950
7 XBRL TAXONOMY EXTENSION SCHEMA bstc-20161231.xsd EX-101.SCH 36792
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20161231_cal.xml EX-101.CAL 49653
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20161231_def.xml EX-101.DEF 157169
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20161231_lab.xml EX-101.LAB 632462
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20161231_pre.xml EX-101.PRE 343667
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34236 | Film No.: 17694671
SIC: 2834 Pharmaceutical Preparations